RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carmen Melendez-Vasquez to Signal Transduction

This is a "connection" page, showing publications Carmen Melendez-Vasquez has written about Signal Transduction.
Connection Strength

0.257
  1. Wang H, Rusielewicz T, Tewari A, Leitman EM, Einheber S, Melendez-Vasquez CV. Myosin II is a negative regulator of oligodendrocyte morphological differentiation. J Neurosci Res. 2012 Aug; 90(8):1547-56.
    View in: PubMed
    Score: 0.220
  2. Dutta DJ, Zameer A, Mariani JN, Zhang J, Asp L, Huynh J, Mahase S, Laitman BM, Argaw AT, Mitiku N, Urbanski M, Melendez-Vasquez CV, Casaccia P, Hayot F, Bottinger EP, Brown CW, John GR. Combinatorial actions of Tgf? and Activin ligands promote oligodendrocyte development and CNS myelination. Development. 2014 Jun; 141(12):2414-28.
    View in: PubMed
    Score: 0.016
  3. Zhang J, Kramer EG, Asp L, Dutta DJ, Navrazhina K, Pham T, Mariani JN, Argaw AT, Melendez-Vasquez CV, John GR. Promoting myelin repair and return of function in multiple sclerosis. FEBS Lett. 2011 Dec 01; 585(23):3813-20.
    View in: PubMed
    Score: 0.013
  4. John GR, Chen L, Rivieccio MA, Melendez-Vasquez CV, Hartley A, Brosnan CF. Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci. 2004 Mar 17; 24(11):2837-45.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support